Update your tester profile Login
  • Register with Our Database

    Get started on the volunteer process by registering your basic information with our database. This information is provided to help us determine your eligibility for current and future studies. We will not share or sell this info with any third party. 

    Thanks for your interest, you'll find the intake form here

  • Study 1610: Healthy Male and Female Participants

    Research Purpose: Study 1610 is designed to evaluate an investigational drug being developed for the treatment of select types of cancers. Participants will receive twice daily oral dose amounts for 6 days and a single dose on Day 7 of the investigational drug or placebo and one oral dose of moxifloxacin. There will be four in clinic stays of 9 days and 8 nights. The following will be  evaluated:

    • Determine the effect of the investigational drug on heart rate and electrical signals related to the heart beats
    • How quickly the body process and eliminates the investigational drug
    • The general safety/tolrability of the investigational

    Minimum Screening Qaulifications:

    Males

    Men are allowed to participate

    Females

    Women must be either post-menopausal or surgically sterile, of childbearing potential using appropriate birth-control  and who are not breast feeding or lactating are allowed to participate.

    Age

    18-55 years

    Body Mass Index (BMI)

    Between 18-32 kg/m²

    Tobacco/Nicotine Use

    No more than the equivalent of 5 cigarettes/week in the 2 months prior to screen.

    Drug Testing

    Must test negative for drugs of abuse.

    Alcohol/Drug Abuse History

    No history of drug or alcohol abuse within 1 year before the screening appointment.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor

    Restricted Medications

    No required regular use of any prescription medications, non-prescription medications, vitamins, or herbal supplements.

     

     

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 13 weeks.

     

    In Clinic Visit Stay

    • Participants will admit to Prism Clinical Research four times for 8 overnights

    Clinic Visits

    • There is one follow-up clinic visit

     

    Compensation for participation time: Up to $8,100

  • Study 1518: Healthy Male and Female Participants

    Research Purpose: Study 1518 is designed to evaluate an investigational drug being developed for the treatment of cancer. Participants will receive up to 3 intravenous (IV) doses of the investigational drug alone or along with companion medications.  The following will be evaluated:

    • How the body’s immune system responds to the investigational drug
    • How quickly the body process and eliminates the investigational drug
    • The general safety/tolerability of the investigational drug

     

    Minimum Screening Qualifications:

     

    Males

    Men are allowed to participate

    Females

    Women are allowed to participate

    Age

    18-65 years

    Tobacco/Nicotine Use

    No more than the equivalent of 10 cigarettes/week in the 3 months prior to screen.  Able and willing to abstain from all tobacco use  for 14 days prior to screen until  the end of the study

    Drug Testing

    Must test negative for drugs of abuse. 

    Alcohol/Drug Abuse History

    No history of drug or alcohol abuse within 1 year before the screening appointment.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor

    Restricted Medications

    No required regular use of any prescription medications, non-prescription medications, vitamins, or herbal supplements not listed below

    Allowed Medications

    Prescribed/stable hormonal birth control is allowed

    Allergy History

    No past or current allergy to baker’s yeast

  • Study 1612: Healthy Female and Male Participants

    Research Purpose: To evaluate the affect of food on absorption and elimination rate of an investigational drug being developed for the treatment of breast cancer.

     

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate

    Females

    Women who are of non-childbearing potential and must meet one of the following criteria: postmenopausal, hysterectomy and/or bilateral oophorectomy, or medically confirmed ovarian failure.

    Age

    18-55 years

    Body Mass Index (BMI)

    Between 17.5 – 30.5 kg/m²

    Tobacco/Nicotine Use

    No use of tobacco/nicotine including electronic cigarettes within 3 months of screening and for the duration of the study.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor

    Restricted Medications

    No prescription, nonprescription drugs, dietary supplements or vitamins 7 days prior to the start of the study through the final study visit.

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 6 weeks.

    Clinic Stay

    • Participants will admit to Prism Clinical Research 3 times.
    • Each clinic stay will last approximately 5 days (4 overnights)

    Clinic Visits

    • There are 2 clinic visits following completion of each clinic stay (6 clinic visits).  

     

     

    Compensation for participation time:  Up to $3,450.00

     
       

     For information regarding this study contact Sarah: 651-368-3360 or sarahl@prismresearchinc.com

  • Non-Drug Studies

    New Non-Drug Study Opportunities Now Available Through Prism Research!

     

    Prism Research is proud to announce that we are now recruiting for non-drug studies!  You or someone you know might be qualified to participate in these studies.

     

    What are Non-Drug Studies?

    Medical devices like auto-injection pens, inhalers, and breast pumps must go through testing before they can be made available to the public.  In Non-Drug Studies, participants will simulate use of a medical device and provide feedback to how easy it was to use the device.  Just like drug-studies, participants receive financial compensation for their time

     

    Who can participate in Non-Drug Studies?

    Anyone who meets the qualifications for a specific study can participate and there will be many future opportunities.  Right now, we are specifically looking for the following people for multiple studies throughout the spring and summer:

     

    • People diagnosed with Rheumatoid Arthritis
    • Caregivers for people with Rheumatoid Arthritis

     

    Email a recuriter or call 651-289-2096 for more info!

Current Studies

Contact a Recruiter

  • Register with Our Database

    Get started on the volunteer process by registering your basic information with our database. This information is provided to help us determine your eligibility for current and future studies. We will not share or sell this info with any third party. 

    Thanks for your interest, you'll find the intake form here

  • Study 1610: Healthy Male and Female Participants

    Research Purpose: Study 1610 is designed to evaluate an investigational drug being developed for the treatment of select types of cancers. Participants will receive twice daily oral dose amounts for 6 days and a single dose on Day 7 of the investigational drug or placebo and one oral dose of moxifloxacin. There will be four in clinic stays of 9 days and 8 nights. The following will be  evaluated:

    • Determine the effect of the investigational drug on heart rate and electrical signals related to the heart beats
    • How quickly the body process and eliminates the investigational drug
    • The general safety/tolrability of the investigational

    Minimum Screening Qaulifications:

    Males

    Men are allowed to participate

    Females

    Women must be either post-menopausal or surgically sterile, of childbearing potential using appropriate birth-control  and who are not breast feeding or lactating are allowed to participate.

    Age

    18-55 years

    Body Mass Index (BMI)

    Between 18-32 kg/m²

    Tobacco/Nicotine Use

    No more than the equivalent of 5 cigarettes/week in the 2 months prior to screen.

    Drug Testing

    Must test negative for drugs of abuse.

    Alcohol/Drug Abuse History

    No history of drug or alcohol abuse within 1 year before the screening appointment.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor

    Restricted Medications

    No required regular use of any prescription medications, non-prescription medications, vitamins, or herbal supplements.

     

     

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 13 weeks.

     

    In Clinic Visit Stay

    • Participants will admit to Prism Clinical Research four times for 8 overnights

    Clinic Visits

    • There is one follow-up clinic visit

     

    Compensation for participation time: Up to $8,100

  • Study 1518: Healthy Male and Female Participants

    Research Purpose: Study 1518 is designed to evaluate an investigational drug being developed for the treatment of cancer. Participants will receive up to 3 intravenous (IV) doses of the investigational drug alone or along with companion medications.  The following will be evaluated:

    • How the body’s immune system responds to the investigational drug
    • How quickly the body process and eliminates the investigational drug
    • The general safety/tolerability of the investigational drug

     

    Minimum Screening Qualifications:

     

    Males

    Men are allowed to participate

    Females

    Women are allowed to participate

    Age

    18-65 years

    Tobacco/Nicotine Use

    No more than the equivalent of 10 cigarettes/week in the 3 months prior to screen.  Able and willing to abstain from all tobacco use  for 14 days prior to screen until  the end of the study

    Drug Testing

    Must test negative for drugs of abuse. 

    Alcohol/Drug Abuse History

    No history of drug or alcohol abuse within 1 year before the screening appointment.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor

    Restricted Medications

    No required regular use of any prescription medications, non-prescription medications, vitamins, or herbal supplements not listed below

    Allowed Medications

    Prescribed/stable hormonal birth control is allowed

    Allergy History

    No past or current allergy to baker’s yeast

  • Study 1612: Healthy Female and Male Participants

    Research Purpose: To evaluate the affect of food on absorption and elimination rate of an investigational drug being developed for the treatment of breast cancer.

     

    Minimum Screening Qualifications:

    Males

    Men are allowed to participate

    Females

    Women who are of non-childbearing potential and must meet one of the following criteria: postmenopausal, hysterectomy and/or bilateral oophorectomy, or medically confirmed ovarian failure.

    Age

    18-55 years

    Body Mass Index (BMI)

    Between 17.5 – 30.5 kg/m²

    Tobacco/Nicotine Use

    No use of tobacco/nicotine including electronic cigarettes within 3 months of screening and for the duration of the study.

    Health History

    Must be healthy; not being evaluated or treated for any medical conditions unless otherwise approved on a case by case basis by the study doctor

    Restricted Medications

    No prescription, nonprescription drugs, dietary supplements or vitamins 7 days prior to the start of the study through the final study visit.

     

    Study Time Commitment: For participants who qualify based on screening evaluation, study participation will last for approximately 6 weeks.

    Clinic Stay

    • Participants will admit to Prism Clinical Research 3 times.
    • Each clinic stay will last approximately 5 days (4 overnights)

    Clinic Visits

    • There are 2 clinic visits following completion of each clinic stay (6 clinic visits).  

     

     

    Compensation for participation time:  Up to $3,450.00

     
       

     For information regarding this study contact Sarah: 651-368-3360 or sarahl@prismresearchinc.com

  • Non-Drug Studies

    New Non-Drug Study Opportunities Now Available Through Prism Research!

     

    Prism Research is proud to announce that we are now recruiting for non-drug studies!  You or someone you know might be qualified to participate in these studies.

     

    What are Non-Drug Studies?

    Medical devices like auto-injection pens, inhalers, and breast pumps must go through testing before they can be made available to the public.  In Non-Drug Studies, participants will simulate use of a medical device and provide feedback to how easy it was to use the device.  Just like drug-studies, participants receive financial compensation for their time

     

    Who can participate in Non-Drug Studies?

    Anyone who meets the qualifications for a specific study can participate and there will be many future opportunities.  Right now, we are specifically looking for the following people for multiple studies throughout the spring and summer:

     

    • People diagnosed with Rheumatoid Arthritis
    • Caregivers for people with Rheumatoid Arthritis

     

    Email a recuriter or call 651-289-2096 for more info!

Please provide us with your contact information (below) and will get back to you as soon as possible.

If you have a general question, check Volunteer FAQ for an answer. If you're unsure of who to contact, please visit the Contact Us page.

Cancel